RecruitingNCT05870163

Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment

A Post-market Registry Study to Assess Safety and Performance of RefluxStop™ in the Treatment of Gastroesophageal Reflux Disease (GERD) in General Hospital Practice

Sponsor

Implantica CE Reflux Ltd.

Enrollment

2,500 participants

Start Date

Feb 20, 2023

Study Type

OBSERVATIONAL

Conditions

Gastroesophageal Reflux Disease (GERD)

Summary

This post-market registry aims to assess safety and performance of RefluxStop™ in the treatment of Gastroesophageal Reflux Disease (GERD) in standard of care procedures.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Nissen fundoplication and a medical device called RefluxStop implantation for people with gastroesophageal reflux disease (gerd). The study is currently recruiting participants at 6 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.